• 1
    Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, et al; Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 947954.
  • 2
    Roberts E, Schilsky ML. A practice guideline on Wilson disease. HEPATOLOGY 2003; 37: 14751492.
  • 3
    Schilsky ML, Sternlieb I. Overcoming obstacles to the diagnosis of Wilson's disease. Gastroenterology 1997: 113: 350353.
  • 4
    Willson RA, Clayson KJ, Leon S. Unmeasurable serum alkaline phosphatase activity in Wilson's disease associated with fulminant hepatic failure and hemolysis. HEPATOLOGY 1987; 7: 613615.
  • 5
    Willson RA, Hartleb M. Fulminant wilsonian hepatitis. Am J Gastroenterol 1988; 83: 13091310.
  • 6
    Steindl P, Ferenci P, Dienes HP, Grimm G, Pabinger I, Madl C, et al. Wilson's disease in patients presenting with liver disease: A diagnostic challenge. Gastroenterology 1997; 113: 212218.
  • 7
    Shaver WA, Bhatt H, Combes B. Low serum alkaline phosphatase activity in Wilson's disease. HEPATOLOGY 1986; 6: 859863.
  • 8
    Lee JJ, Kim HJ, Chung IJ, Kook H, Byun JR, Kwon SY, et al. Acute hemolytic crisis with fulminant hepatic failure as the first manifestation of Wilson's disease: A case report. J Korean Med Sci 1998; 13: 548550.
  • 9
    Hoshino T, Kumasaka K, Kawano K, Yamagishi F, Koyama I, Fujimori-Arai Y, et al. Low serum alkaline phosphatase activity associated with severe Wilson's disease. is the breakdown of alkaline phosphatase molecules caused by reactive oxygen species? Clin Chim Act 1995; 238: 91100.
  • 10
    Schilsky ML. Diagnosis and treatment of Wilson's disease. Pediatr Transplant 2002; 6: 1519.
  • 11
    McCullough AJ, Fleming CR, Thistle JL, Baldus WP, Ludwig J, McCall JT, et al. Diagnosis of Wilson's disease presenting as fulminant hepatic failure. Gastroenterology 1983; 84: 161167.
  • 12
    Berman DH, Leventhal RI, Gavaler JS, Cadoff EM, Van Thiel DH. Clinical differentiation of fulminant wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 1991; 100: 11291134.
  • 13
    Sallie R, Katsiyiannakis L, Baldwin D, Davies S, O'Grady J, Mowat A, et al. Failure of simple biochemical indexes to reliably differentiate fulminant Wilson's disease from other causes of fulminant liver failure. HEPATOLOGY 1992; 16: 12061211.
  • 14
    Morell AG, Windsor J, Sternlieb I, Scheinberg IH. Measurement of the concentration of ceruloplasmin by dermination of its oxidase activity. In: Sunderman SW, Sunderman SW Jr, editors. Laboratory Diagnosis of Liver Diseases. St. Louis, MO: Warren H. Green; 1968: 103195.
  • 15
    Schilsky ML, Quintana N, Volenberg I, Kabishcher V, Sternlieb I. Spontaneous cholangiofibrosis in Long–Evans Cinnamon rats: A rodent model for Wilson's disease. Lab Anim Sci 1998, 48: 156161.
  • 16
    Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. HEPATOLOGY 2001; 33: 464470.
  • 17
    Schilsky ML, Tavill AS. Wilson Disease. In Schiff ER, Sorrell MF, Maddrey WC, editors. Schiff's Diseases of the Liver. Tenth ed. Philadelphia, PA: Lippincott-Williams and Wilkins; 2007: 10231106.
  • 18
    Gow PJ, Smallwood RA, Angus PW, Smith AL, Wall AJ, Sewell RB. Diagnosis of Wilson's disease: An experience over three decades. Gut 2000; 46: 415419.
  • 19
    Ring-Larsen H, Pallazo U. Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis. Gut 1981, 22: 585591.
  • 20
    Schilsky ML, Scheinberg IH, Sternlieb I. Hepatic transplantation for Wilson's disease: Indication and outcome. Hepatology 1994; 19: 583587.
  • 21
    Emre S, Atillasoy EO, Ozdemir S, Schilsky ML, Rathna Varma CVR, Thung SN, et al. Orthotopic liver transplantation for Wilson's disease: a single center experience. Transplantation 2001; 72: 12321236.
  • 22
    Sokol RJ, Frances PD, Gold SH, Ford DM, Lum GM, Ambruso DR. Orthotopic liver transplantation for acute fulminant Wilson disease. J Pediatr 1985, 107: 549552.
  • 23
    Auth MK, Kim HS, Beste M, Bonzel KE, Baumann U, Ballauff A, et al. Removal of metabolites, cytokines and hepatic growth factors by extracorporeal liver support in children. J Pediatr Gastroenterol Nutr 2005; 40: 5459.
  • 24
    Kreymann B, Seige M, Schweigart U, Kopp KF, Classen M. Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol 1999; 31: 10801085.
  • 25
    Rakela J, Kurtz SB, McCarthy JT, Ludwig J, Ascher NL, Bloomer JR, et al. Fulminant Wilson's disease treated with postdilution hemofiltration and orthotopic liver transplantation. Gastroenterology 1986; 90: 20042007.